Abstract

BackgroundInterferon-α (IFN-α) is increased and plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Plasmacytoid dendritic cells (pDCs) are the main producer of IFN-α, but their IFN-α producing capacity has been shown to be unchanged or reduced when stimulated with a Toll-like receptor 9 (TLR9) agonist in patients with SLE compared to in healthy individuals. In this study, we investigated the IFN-α-producing capacity of lupus pDCs under different stimulation.MethodspDCs from patients with SLE and healthy controls (HC) were stimulated with TLR9 or TLR7 agonist, and their IFN-α producing capacity was examined by intracellular cytokine staining and flow cytometry. The correlation of IFN-α-producing capacity with serum IFN-α levels and disease activity was assessed. The effect of in vitro IFN-α exposure on IFN-α production by pDCs was examined. Localization of TLR7 in cellular compartments in pDCs was investigated.ResultsThe IFN-α producing capacity of pDCs was reduced after TLR9 stimulation, but increased when stimulated with a TLR7 agonist in SLE compared to in HC. IFN-α production by pDCs upon TLR9 stimulation was reduced and the percentage of IFN-α+pDC was inversely correlated with disease activity and serum IFN-α levels. However, the TLR7 agonist-induced IFN-α producing capacity of lupus pDCs was enhanced and correlated with disease activity and serum IFN-α. Exposure to IFN-α enhanced IFN-α production of TLR7-stimulated pDCs, but reduced that of pDCs activated with a TLR9 agonist. TLR7 localization was increased in late endosome/lysosome compartments in pDCs from SLE patients.ConclusionsThese findings indicate that enhanced TLR7 responses of lupus pDCs, owing to TLR7 retention in late endosome/lysosome and exposure to IFN-α, are associated with the pathogenesis of SLE.

Highlights

  • Interferon-α (IFN-α) is increased and plays an important role in the pathogenesis of systemic lupus erythematosus (SLE)

  • IFN-α production by Plasmacytoid dendritic cells (pDC) upon Toll-like receptor 9 (TLR9) stimulation was reduced and inversely correlated with disease activity in SLE We first investigated IFN-α production by pDCs stimulated with a TLR9 ligand, CpG ODN2216 in patients with SLE and healthy controls (HC)

  • There was no statistical difference in the percentages of IFN-α+ pDCs between patients with inactive and active SLE, there was greater reduction in the percentage of IFN-α+ pDCs in patients with active disease compared to in HC (Fig. 1a). pDCs produced Tumor necrosis factor (TNF)-α when stimulated with CpG

Read more

Summary

Introduction

Interferon-α (IFN-α) is increased and plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Plasmacytoid dendritic cells (pDCs) are the main producer of IFN-α, but their IFN-α producing capacity has been shown to be unchanged or reduced when stimulated with a Toll-like receptor 9 (TLR9) agonist in patients with SLE compared to in healthy individuals. Other reports show that IFN-α production by PBMCs or pDCs after stimulation with herpes simplex virus, Sendai virus, or CpG oligodeoxyribonucleotide (ODN) is reduced in patients with SLE [41,42,43,44,45]. These findings suggest that the IFN-α-producing capacity of lupus pDCs varies depending on the type of stimuli

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call